Phase 2 Cancer Patients Clinical Trials
18 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–18 of 18 trials
Recruiting
Phase 2
Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC.
Rectal Cancer Patients
Sun Yat-sen University88 enrolled1 locationNCT06911684
Recruiting
Phase 2
Pinoxin for the Prevention of Radiation-Induced Skin Injury
Cancer Patients Undergoning Radiotherapy
Fudan University202 enrolled2 locationsNCT07545720
Recruiting
Phase 2
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Prostate Cancer (Adenocarcinoma)Prostate Cancer Patients Treated by Radiotherapy
Candel Therapeutics, Inc.45 enrolled7 locationsNCT07332000
Recruiting
Phase 2
Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）
Rectal Cancer Patients
The Affiliated Hospital of Qingdao University35 enrolled1 locationNCT06647680
Recruiting
Phase 2
Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining)
Peritoneal CarcinomatosisAbdominal CancerPeritoneal (Metastatic) Cancer+1 more
Patrick Wagner, MD, FACS200 enrolled1 locationNCT07282834
Recruiting
Phase 2
Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
Prostate CancerProstate Cancer Patients Treated by Radiotherapy
Medical University of South Carolina46 enrolled1 locationNCT07325721
Recruiting
Phase 2Phase 3
A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients
Prostate Cancer Patients
Shanghai Jiao Tong University School of Medicine300 enrolled2 locationsNCT03258320
Recruiting
Phase 2
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
HER2-negative Breast Cancer Patients With Brain Metastases
Biostar Pharma, Inc.120 enrolled17 locationsNCT06764940
Recruiting
Phase 2
Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and Durvalumab
Non-small-cell Lung Cancer Patients
Fondazione Ricerca Traslazionale176 enrolled1 locationNCT05568212
Recruiting
Phase 2
SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC
Rectal CancerRectal AdenocarcinomaTargeted Therapy+6 more
Ruijin Hospital104 enrolled1 locationNCT07198165
Recruiting
Phase 2
Trastuzumab Deruxtecan vs Endocrine Therapy in Low-HER2 HR+ Advanced Breast Cancer
Hormone Receptor(HR)-Positive, Low HER2 Advanced Breast Cancer Patients (HER2 IHC 1+ or 2+ & ISH Negative)
Yonsei University141 enrolled1 locationNCT06837792
Recruiting
Phase 1Phase 2
Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of Acute Radiation Skin Injury
To Evaluate the Safety of Taurine in Preventing Acute Radiation Skin Injury Induced by Adjuvant Radiotherapy in Breast Cancer Patients
Shandong Cancer Hospital and Institute24 enrolled1 locationNCT06847555
Recruiting
Phase 2
To Evaluate Dose and Safety of NanoEcho Particle-1 Using NanoEcho Imaging Device Examinations of Rectal Lymph Nodes in Healthy Volunteers and Rectal Cancer Patients.
Healthy VolunteersRectal Cancer Patients
NanoEcho AB12 enrolled1 locationNCT06693375
Recruiting
Phase 2
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
Prostate CancerProstate CancersProstate Cancer (Adenocarcinoma)+4 more
Cellvax Therapeutics Inc100 enrolled3 locationsNCT06636682
Recruiting
Phase 2
Treatment of Pulmonary SUlcus, Pancoast and Chest Wall Non-small Cell Lung Cancer Employing Radiation, Immuno-oncology and Resection
Non-small Cell Lung Cancer (NSCLC)Lung Cancer Patients
Marc de Perrot12 enrolled1 locationNCT06331455
Recruiting
Phase 2
Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance
Prostate Cancer Patients on Active Surveillance
Ashutosh Kumar Tewari114 enrolled1 locationNCT06343077
Recruiting
Phase 2Phase 3
A Randomized Trial Compared the Efficacy and Safety of Combined Use of Indocyanine Green Fluorescence and Methylene Blue Dye Versus Methylene Blue Dye alone for Sentinel Lymph Node Biopsy in Breast Cancer Patients
Sentinel Lymph Node Biopsy in Breast Cancer Patients
Peking University People's Hospital Breast Cancer Center100 enrolled1 locationACTRN12612000109808
Completed
Phase 2
Zometa as a prophylactic treatment for bone mineral density loss in cancer patients following allogeneic stem cell transplantation
Loss of bone mineral density in cancer patients whom have undergone allogeneic stem cell transplantation
Australasian Leukaemia and Lymphoma Group120 enrolled1 locationACTRN12607000596404